Human α2β1HI CD133+VE Epithelial Prostate Stem Cells Express Low Levels of Active Androgen Receptor

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Williamson, Stuart C ^a   Hepburn, Anastasia C ^a   Wilson, Laura ^a   Coffey, Kelly ^a   Ryan Munden, Claudia A ^a   Pal, Deepali ^a   Leung, Hing Y ^b   Robson, Craig N ^a   Heer, Rakesh ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CD133 ANTIGEN; CELL PROTEIN; HUMAN ALPHA2BETA1HIGH CD133+VE ANTIGEN; HUMAN ALPHA2BETA1LOW CD133+VE ANTIGEN; PROSTATE SPECIFIC ANTIGEN; PROTEIN KLK2; PROTEIN TMPRSS2; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL ISOLATION; CELL POPULATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT TRANSFORMATION; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; PROTEIN FUNCTION; STEM CELL;

ANTIGENS, CD; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; GENE EXPRESSION; GLYCOPROTEINS; HUMANS; MALE; NEOPLASTIC STEM CELLS; PEPTIDES; PROSTATE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; SERINE ENDOPEPTIDASES; STEM CELLS;

EID: 84868699649     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048944     Document Type: Article

References (40)

1. Haffner MC, Aryee MJ, Toubaji A, Esopi DM, Albadine R, et al. (2010) Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements. Nat Genet 42: 668-675.
2. Lin C, Yang L, Tanasa B, Hutt K, Ju BG, et al. (2009) Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer. Cell 139: 1069-1083.
3. Yu J, Mani RS, Cao Q, Brenner CJ, Cao X, et al. (2010) An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. Cancer Cell 17: 443-454.
4. Attard G, Cooper CS, de Bono JS, (2009) Steroid hormone receptors in prostate cancer: a hard habit to break? Cancer Cell 16: 458-462.
5. Bonkhoff H, Berges R, (2010) From pathogenesis to prevention of castration resistant prostate cancer. Prostate 70: 100-112.
6. Goldstein AS, Huang J, Guo C, Garraway IP, Witte ON, (2010) Identification of a cell of origin for human prostate cancer. Science 329: 568-571.
7. Lawson DA, Zong Y, Memarzadeh S, Xin L, Huang J, et al. (2010) Basal epithelial stem cells are efficient targets for prostate cancer initiation. Proc Natl Acad Sci U S A 107: 2610-2615.
8. Owens DM, Watt FM, (2003) Contribution of stem cells and differentiated cells to epidermal tumours. Nat Rev Cancer 3: 444-451.
9. Perez-Losada J, Balmain A, (2003) Stem-cell hierarchy in skin cancer. Nat Rev Cancer 3: 434-443.
10. Leong KG, Wang BE, Johnson L, Gao WQ, (2008) Generation of a prostate from a single adult stem cell. Nature 456: 804-808.
11. Wang X, Kruithof-de Julio M, Economides KD, Walker D, Yu H, et al. (2009) A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 461: 495-500.
12. Blackwood JK, Williamson SC, Greaves LC, Wilson L, Rigas AC, et al. (2011) In situ lineage tracking of human prostatic epithelial stem cell fate reveals a common clonal origin for basal and luminal cells. J Pathol 225: 181-188.
13. Gaisa NT, Graham TA, McDonald SA, Poulsom R, Heidenreich A, et al. (2011) Clonal architecture of human prostatic epithelium in benign and malignant conditions. J Pathol 225: 172-180.
14. Richardson GD, Robson CN, Lang SH, Neal DE, Maitland NJ, et al. (2004) CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci 117: 3539-3545.
15. Heer R, Collins AT, Robson CN, Shenton BK, Leung HY, (2006) KGF suppresses alpha2beta1 integrin function and promotes differentiation of the transient amplifying population in human prostatic epithelium. J Cell Sci 119: 1416-1424.
16. Collins AT, Habib FK, Maitland NJ, Neal DE, (2001) Identification and isolation of human prostate epithelial stem cells based on alpha(2)beta(1)-integrin expression. J Cell Sci 114: 3865-3872.
17. Litvinov IV, Vander Griend DJ, Xu Y, Antony L, Dalrymple SL, et al. (2006) Low-calcium serum-free defined medium selects for growth of normal prostatic epithelial stem cells. Cancer Res 66: 8598-8607.
18. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ, (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65: 10946-10951.
19. Mousses S, Wagner U, Chen Y, Kim JW, Bubendorf L, et al. (2001) Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signaling. Oncogene 20: 6718-6723.
20. Buchanan G, Irvine RA, Coetzee GA, Tilley WD, (2001) Contribution of the androgen receptor to prostate cancer predisposition and progression. Cancer Metastasis Rev 20: 207-223.
21. Chen CD, Welsbie DS, Tran C, Baek SH, Chen R, et al. (2004) Molecular determinants of resistance to antiandrogen therapy. Nat Med 10: 33-39.
22. Kolli S, Lako M, Figueiredo F, Mudhar H, Ahmad S, (2008) Loss of corneal epithelial stem cell properties in outgrowths from human limbal explants cultured on intact amniotic membrane. Regen Med 3: 329-342.
23. Birgersdotter A, Sandberg R, Ernberg I, (2005) Gene expression perturbation in vitro-a growing case for three-dimensional (3D) culture systems. Semin Cancer Biol 15: 405-412.
24. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, et al. (2000) Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 24: 227-235.
25. van der Loos CM, (2008) Multiple immunoenzyme staining: methods and visualizations for the observation with spectral imaging. J Histochem Cytochem 56: 313-328.
26. Shepherd CJ, Rizzo S, Ledaki I, Davies M, Brewer D, et al. (2008) Expression profiling of CD133+ and CD133- epithelial cells from human prostate. Prostate 68: 1007-1024.
27. Platet N, Liu SY, Atifi ME, Oliver L, Vallette FM, et al. (2007) Influence of oxygen tension on CD133 phenotype in human glioma cell cultures. Cancer Lett 258: 286-290.
28. Heer R, Robson CN, Shenton BK, Leung HY, (2007) The role of androgen in determining differentiation and regulation of androgen receptor expression in the human prostatic epithelium transient amplifying population. J Cell Physiol 212: 572-578.
29. Patrawala L, Calhoun-Davis T, Schneider-Broussard R, Tang DG, (2007) Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells. Cancer Res 67: 6796-6805.
30. Corbeil D, Marzesco AM, Wilsch-Brauninger M, Huttner WB, (2010) The intriguing links between prominin-1 (CD133), cholesterol-based membrane microdomains, remodeling of apical plasma membrane protrusions, extracellular membrane particles, and (neuro)epithelial cell differentiation. FEBS Lett 584: 1659-1664.
31. Bonkhoff H, Remberger K, (1993) Widespread distribution of nuclear androgen receptors in the basal cell layer of the normal and hyperplastic human prostate. Virchows Arch A Pathol Anat Histopathol 422: 35-38.
32. Cai C, He HH, Chen S, Coleman I, Wang H, et al. (2011) Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1. Cancer Cell 20: 457-471.
33. Kemppainen JA, Lane MV, Sar M, Wilson EM, (1992) Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones. J Biol Chem 267: 968-974.
34. Vander Griend DJ, Karthaus WL, Dalrymple S, Meeker A, DeMarzo AM, et al. (2008) The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells. Cancer Res 68: 9703-9711.
35. Lee SO, Tian J, Huang CK, Ma Z, Lai KP, et al. (2012) Suppressor role of androgen receptor in proliferation of prostate basal epithelial and progenitor cells. J Endocrinol 213: 173-182.
36. Lamb LE, Knudsen BS, Miranti CK, (2010) E-cadherin-mediated survival of androgen-receptor-expressing secretory prostate epithelial cells derived from a stratified in vitro differentiation model. J Cell Sci 123: 266-276.
37. Cunha GR, (2008) Mesenchymal-epithelial interactions: past, present, and future. Differentiation 76: 578-586.
38. Rajasekhar VK, Studer L, Gerald W, Socci ND, Scher HI, (2011) Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-kappaB signalling. Nat Commun 2: 162.
39. Bae KM, Su Z, Frye C, McClellan S, Allan RW, et al. (2010) Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells. J Urol 183: 2045-2053.
40. Kumar SM, Liu S, Lu H, Zhang H, Zhang PJ, et al. (2012) Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation. Oncogene.